Asymmetry of VANGL2 in migrating lymphocytes as a tool to monitor activity of the mammalian WNT/planar cell polarity pathway

Cell Communication and Signaling

Volumn 13, Issue 1, 2015, Pages

  Kaucká, Markéta ^a,b   Petersen, Julian ^b   Janovská, Pavlína ^a   Radaszkiewicz, Tomasz ^a   Smyèková, Lucie ^a   Daulat, Avais M ^c,d,e   Borg, Jean Paul ^c,d,e   Schulte, Gunnar ^a,b   Bryja, Vitezslav ^a,f  

^a MASARYK UNIVERSITY   (Czech Republic)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AIX MARSEILLE UNIVERSITY   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

B lymphocyte; Casein kinase 1; MEC1; Migration; Planar cell polarity; VANGL2

Indexed keywords

CELL PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG; VAN GOGH LIKE 2 PROTEIN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; VANGL2 PROTEIN, HUMAN;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CELL POLARITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; WNT SIGNALING PATHWAY; CELL MOTION; CHRONIC LYMPHATIC LEUKEMIA; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

MAMMALIA;

B-LYMPHOCYTES; CELL LINE, TUMOR; CELL MOVEMENT; CELL POLARITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MEMBRANE PROTEINS; WNT SIGNALING PATHWAY;

EID: 84928662409     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/s12964-014-0079-1     Document Type: Article

References (41)

1. Seifert JR, Mlodzik M. Frizzled/PCP signalling: a conserved mechanism regulating cell polarity and directed motility. Nat Rev Genet. 2007;8:126-38.
2. Wallingford JB. Planar cell polarity and the developmental control of cell behavior in vertebrate embryos. Annu Rev Cell Dev Biol. 2012;28:627-53.
3. Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012;151:1542-56.
4. Chen YL, Wang TH, Hsu HC, Yuan RH, Jeng YM. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS One. 2013;8:e70324.
5. Jessen JR. Noncanonical Wnt signaling in tumor progression and metastasis. Zebrafish. 2009;6:21-8.
6. Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther. 2009;8:2103-9.
7. Ezan J, Montcouquiol M. Revisiting planar cell polarity in the inner ear. Semin Cell Dev Biol. 2013;24:499-506.
8. Tissir F, Goffinet AM. Planar cell polarity signaling in neural development. Curr Opin Neurobiol. 2010;20:572-7.
9. Gao B, Song H, Bishop K, Elliot G, Garrett L, English MA, et al. Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2. Dev Cell. 2011;20:163-76.
10. Kaucká M, Plevová K, Pavlová S, Janovská P, Mishra A, Verner J, et al. The planar cell polarity pathway drives pathogenesis of chronic lymphocytic leukemia by the regulation of B-lymphocyte migration. Cancer Res. 2013;73:1491-501.
11. Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D, et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res. 1999;23:127-36.
12. Bertilaccio MT, Scielzo C, Simonetti G, Ponzoni M, Apollonio B, Fazi C, et al. A novel Rag2-/-gammac-/-xenograft model of human CLL. Blood. 2010;115:1605-9.
13. Zicha D, Dunn GA, Brown AF. A new direct-viewing chemotaxis chamber. J Cell Sci. 1991;99(Pt 4):769-75.
14. Vladar EK, Antic D, Axelrod JD. Planar cell polarity signaling: the developing cell's compass. Cold Spring Harb Perspect Biol. 2009;1:a002964.
15. del Pozo MA, Sanchez-Mateos P, Nieto M, Sanchez-Madrid F. Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J Cell Biol. 1995;131:495-508.
16. Bryja V, Schambony A, Cajanek L, Dominguez I, Arenas E, Schulte G. Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep. 2008;9:1244-50.
17. Kim GH, Han JK. Essential role for beta-arrestin 2 in the regulation of Xenopus convergent extension movements. Embo J. 2007;26:2513-26.
18. Wallingford JB, Habas R. The developmental biology of Dishevelled: an enigmatic protein governing cell fate and cell polarity. Development. 2005;132:4421-36.
19. Witze ES, Litman ES, Argast GM, Moon RT, Ahn NG. Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science. 2008;320:365-9.
20. Proffitt KD, Madan B, Ke Z, Pendharkar V, Ding L, Lee MA, et al. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res. 2013;73:502-7.
21. Rena G, Bain J, Elliott M, Cohen P. D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a. EMBO Rep. 2004;5:60-5.
22. Bryja V, Schulte G, Arenas E. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. Cell Signal. 2007;19:610-6.
23. Bryja V, Schulte G, Rawal N, Grahn A, Arenas E. Wnt-5a induces Dishevelled phosphorylation and dopaminergic differentiation via a CK1-dependent mechanism. J Cell Sci. 2007;120:586-95.
24. Kani S, Oishi I, Yamamoto H, Yoda A, Suzuki H, Nomachi A, et al. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Iepsilon. J Biol Chem. 2004;279:50102-9.
25. Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A. 2013;110:20224-9.
26. Kele J, Andersson ER, Villaescusa JC, Cajanek L, Parish CL, Bonilla S, et al. SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells. Stem Cells. 2012;30:865-75.
27. Mlodzik M. Planar polarity in the Drosophila eye: a multifaceted view of signaling specificity and cross-talk. EMBO J. 1999;18:6873-9.
28. Devenport D. The cell biology of planar cell polarity. J Cell Biol. 2014;207:171-9.
29. Ulrich F, Concha ML, Heid PJ, Voss E, Witzel S, Roehl H, et al. Slb/Wnt11 controls hypoblast cell migration and morphogenesis at the onset of zebrafish gastrulation. Development. 2003;130:5375-84.
30. Witzel S, Zimyanin V, Carreira-Barbosa F, Tada M, Heisenberg CP. Wnt11 controls cell contact persistence by local accumulation of Frizzled 7 at the plasma membrane. J Cell Biol. 2006;175:791-802.
31. Gros J, Serralbo O, Marcelle C. WNT11 acts as a directional cue to organize the elongation of early muscle fibres. Nature. 2009;457:589-93.
32. Wu J, Roman AC, Carvajal-Gonzalez JM, Mlodzik M. Wg and Wnt4 provide long-range directional input to planar cell polarity orientation in Drosophila. Nat Cell Biol. 2013;15:1045.
33. Gao B. Wnt regulation of planar cell polarity (PCP). Curr Top Dev Biol. 2012;101:263-95.
34. Kallay LM, McNickle A, Brennwald PJ, Hubbard AL, Braiterman LT. Scribble associates with two polarity proteins, Lgl2 and Vangl2, via distinct molecular domains. J Cell Biochem. 2006;99:647-64.
35. Feike AC, Rachor K, Gentzel M, Schambony A. Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA. Biochem Biophys Res Commun. 2010;400:500-6.
36. Bryja V, Gradl D, Schambony A, Arenas E, Schulte G. Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci U S A. 2007;104:6690-5.
37. Lindqvist M, Horn Z, Bryja V, Schulte G, Papachristou P, Ajima R, et al. Vang-like protein 2 and Rac1 interact to regulate adherens junctions. J Cell Sci. 2010;123:472-83.
38. Peters JM, McKay RM, McKay JP, Graff JM. Casein kinase I transduces Wnt signals. Nature. 1999;401:345-50.
39. Angers S, Thorpe CJ, Biechele TL, Goldenberg SJ, Zheng N, MacCoss MJ, et al. The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat Cell Biol. 2006;8:348-57.
40. Bernatik O, Ganji RS, Dijksterhuis JP, Konik P, Cervenka I, Polonio T, et al. Sequential activation and inactivation of Dishevelled in the Wnt/betacatenin pathway by casein kinases. J Biol Chem. 2011;286:10396-410.
41. Belotti E, Puvirajesinghe TM, Audebert S, Baudelet E, Camoin L, Pierres M, et al. Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes. PLoS One. 2012;7:e46213.